Introduction
Severe postoperative lymphatic leakage may become lifethreatening for several reasons, including malnutrition following hypoalbuminemia and immunologic dysfunctions owing to the loss of lymphocytes. 1 Conservative therapies, such as a nonfat diet, oral intake cessation, and the administration of octreotide, are indicated as first-line therapies and are effective in approximately 66% to 77% of patients. [2] [3] [4] [5] Lymphography using lipiodol is effective for localizing the site of lymphatic leakage as well as treating the leakage site by inflammatory reactions in 50% of nonresponding patients. 6 A novel method, percutaneous embolization using N-butyl cyanoacrylate (NBCA), was recently reported to be useful for cases of severe lymphorrhea, [6] [7] [8] [9] [10] [11] [12] and involves the following: (1) embolization of a lympho-pseudoaneurysm (LPA embolization), which is embolization of the sac-like space formed by lymphatic fluid (potentially easier than [2] [3] ), (2) embolization of upstream lymph nodes (ULN embolization), which requires upstream lymph nodes (LN), and (3) embolization of upstream lymphatic vessels (ULV embolization). We herein present a case of severe postoperative lymphatic leakage that was successfully treated by LPA embolization followed by ULV embolization.
Case Report
A 73-year-old Japanese man (SMIC-Uro #9798, a unique nonsequential patient control number in the Department of Urooncology, Saitama Medical University International Medical Center) was referred to the Department of Uro-oncology, Saitama Medical University International Medical Center for the further evaluation of a renal tumor. Computed tomography (CT) showed a right renal tumor (135 mm in diameter) that was enhanced by contrast medium, a tumor thrombus from the renal vein to right atrium (* in Figure 1A ), multiple LN metastases in the right paracaval, intra-aortocaval, and left para-aortic areas (maximum size: 34.7 mm; yellow arrowheads in Figure 1A ), as well as multiple lung metastases (maximum size: 19.4 mm; data not shown), leading to a diagnosis of metastatic right renal cell carcinoma (clinical T3cN2M1). He underwent right cytoreductive nephrectomy,
Clinical Practice Points
Severe postoperative lymphatic leakage is lifethreatening and has been treated by conservative therapies and lymphography; however, many cases are not cured by these treatments. Percutaneous embolization using N-butyl cyanoacrylate, superglue for the human body, has recently been reported as a safe and effective treatment for cases of intractable lymphatic leakage. We encountered a case of severe lymphatic leakage after aggressive right cytoreductive nephrectomy that was successfully treated with N-butyl cyanoacrylate embolization. We herein report the method employed with informative figures and videos in addition to a literature review. A detailed description of the method used to treat the present case will provide beneficial information for the treatment of patients with severe lymphatic leakage and development of better procedures in the future.
extended LN dissection (metastases were pathologically detected in 6 of 12 LNs), and resection of the tumor thrombus with inferior vena cavectomy, and synthetic vessel graft replacement. No complications were reported, except for chylous leakage from the drainage tube (1000-2000 mL per day), which persisted for more than 3 months and was resistant to conservative therapies. He developed hypoalbuminemia (2.1 g/dL on postoperative day [POD] 10) and severe edema in his lower extremity.
Lymphography was performed 95 days after surgery using lipiodol, as previously described. 13 The patient was placed in the supine position, and a 23-gauge cathelin needle (Terumo, Tokyo, Japan) was inserted into the right inguinal LN. Six milliliters of lipiodol (Guerbet Japan, Tokyo, Japan) was injected at a rate of approximately 0.1 mL per minute under fluoroscopy. Lymphography identified a lymphatic pool, called an LPA, 6 at the dissection site of para-aortic LN (yellow arrowheads in Figure 1B ). However, lymphatic leakage did not improve thereafter. On POD 139, he underwent NBCA embolization directly into the LPA, as described below. 6 He underwent lipiodol lymphography in the supine position wearing The Fast Find Grid (Webb Medical LLC, Philadelphia, PA) (white dots that are identified on the back side of axial CT images; see Supplemental Figure 1 in the online version) followed by cone beam CT (CBCT), which generated axial (see Supplemental Figure 1 in the online version), coronal (see Supplemental Figure 2 in the online version), and sagittal (see Supplemental Figure 3 in the online version) tomography images. A safe and feasible puncture route was identified with a 3-dimensional video with grids (see Supplemental Video 1 in the online version), which was reconstructed from CBCT images (see Supplemental  Figures 1-3 in the online version). A 21-gauge Chiba needle (Create Medic, Kanagawa, Japan) was percutaneously inserted into the LPA through the left side of the third lumbar vertebra. We confirmed the drainage of 0.5 mL of lymphatic fluid. CBCT was performed again in order to confirm the location of the needle tip (see Supplemental Video 2 in the online version). A mixture of 1 mL of NBCA (B. Braun Melsungen AG, Melsungen, Germany) and 0.1 mL of lipiodol was injected into the LPA (* in Figure 1C ; also see Supplemental Video 3 in the online version). However, the volume of lymphatic leakage did not subsequently decrease. Seven days after the first embolization (on POD 146), mild septicemia with Escherichia coli (body temperature: 38.5 C) was reported, which may have occurred owing to a low albumin level (1.9 g/dL) and immunologic dysfunction rather than as a complication of embolization. Twenty-one days after the first embolization (on POD 160), he underwent a second embolization as described below. CBCT was performed to confirm the previous pool of NBCA and lipiodol (aqua arrow; see Supplemental Video 4 in the online version). Lipiodol lymphography was performed and extravasation was identified (green arrow; see Supplemental Video 5 in the online version) above a previous pool of NBCA and lipiodol. A 21-gauge needle was inserted directly into the upstream lymph vessel of extravasation under fluoroscopy. A mixture of 0.5 mL of NBCA and 1 mL of lipiodol was injected directly into the upstream lymph vessel ( Figure 1D ). The leakage point was gradually occluded by NBCA with lipiodol (green arrowheads; see Supplemental Video 6 in the online version), and the mixture finally clotted in another lymph vessel branch that was also upstream of the leakage (pink arrowheads; see Supplemental Video 6 in the online version). After the procedure, lymphatic leakage successfully resolved.
Discussion
We herein present a case of severe lymphorrhea that was successfully treated by LPA embolization followed by ULV embolization, the procedures shown in the Figures and Supplemental Videos. Table 1 shows previous cases of postoperative lymphatic leakage treated by NBCA embolization including the present case. Six (33.3%, bold characters in the column "Surgery" in Table 1 ) and 7 (38.9%, italic) cases underwent urologic and gynecologic surgeries, respectively, which suggests that NBCA embolization is suitable for retroperitoneal and pelvic surgeries. Six cases (33.3%), including the present case, exhibited lymphatic leakage after para-aortic LN dissection, and were treated using ULV embolization, indicating that ULV embolization is appropriate for para-aortic lymphatic ducts. LPA embolization may be easier to perform than ULN or ULV embolization because the LPA space is generally larger than lymphatic vessels and nodes. However, lymphatic leakage was successfully treated by LPA embolization in only 5 out of 13 cases (38.5%, * in Table 1 ). This may have been because the NBCA mass was not sufficient to obstruct the LPA, as observed in the present case (green arrowheads in Figure 1D ). In cases of LPA embolization failure, cases 12, 16, 17 , and the present case needed ULN or ULV.
The technique for ULV embolization is challenging and requires the skill of an expert radioangiographer because lymphatic vessels are tiny. However, once it is successful, ULV embolization has a higher (60.0%) ( Table 1 ) success rate than LPA embolization. ULV embolization may not be effective for cases of leakage owing to multilymphatic vessels (eg, cases 8, 9, and 17). In order to fill longer and/or more vessels, we utilized thinner NBCA for ULV embolization than for LPA embolization. Not only the extra space in LPA (green arrowheads in Figure 1D ), but also a large number of lymphatic vessels (pink arrowheads) were embolized, leading to the successful treatment of this case. No major complications related to NBCA embolization were reported, except for mild transient leg edema. 6 Although no guidelines have been reported for the treatment of postoperative lymphatic leakage, some studies employed a conventional sequential approach using a nonfat diet, oral intake cessation, and the administration of octreotide for several weeks up to 2 months. 14, 15 Other studies indicated that earlier radiologic interventions are preferable, particularly in severe cases with lymphatic leakage of greater than 1000 to 1500 mL/day. 16, 17 Further case reports and/or clinical studies are needed in order to establish an appropriate treatment strategy; however, we are currently performing earlier radiologic interventions in an attempt to reduce hospital stays, discomfort owing to complications including hypoalbuminemia, and costs.
Conclusion
We encountered a case of severe lymphatic leakage resistant to conservative therapies and lipiodol lymphography that was successfully treated by percutaneous embolization using NBCA. We herein presented the detailed method of the technique, which will be informative for other cases.
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